Market Cap : 32.73 B | Enterprise Value : 33.99 B | PE Ratio : 45.29 | PB Ratio : 3.00 |
---|
NAS:ILMN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ILMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Illumina's Average Total Inventories for the three months ended in Mar. 2022 was $448 Mil. Illumina's Cost of Goods Sold for the three months ended in Mar. 2022 was $408 Mil. Hence, Illumina's Days Inventory for the three months ended in Mar. 2022 was 100.20.
The historical rank and industry rank for Illumina's Days Inventory or its related term are showing as below:
During the past 13 years, Illumina's highest Days Inventory was 142.30. The lowest was 106.81. And the median was 126.00.
Illumina's Days Inventory declined from Mar. 2021 (102.07) to Mar. 2022 (100.20).
Inventory Turnover measures how fast the company turns over its inventory within a year. Illumina's Inventory Turnover for the three months ended in Mar. 2022 was 0.91.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Illumina's Inventory-to-Revenue for the three months ended in Mar. 2022 was 0.37.
The historical data trend for Illumina's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Illumina's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Days Inventory distribution charts can be found below:
* The bar in red indicates where Illumina's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Illumina's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as
Days Inventory (A: Dec. 2021 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2020 ) | + | Total Inventories (A: Dec. 2021 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2021 ) | * | Days in Period |
= | ( (372 | + | 431) | / | 2 ) | / | 1372 | * | 365 |
= | 401.5 | / | 1372 | * | 365 | ||||
= | 106.81 |
Illumina's Days Inventory for the quarter that ended in Mar. 2022 is calculated as:
Days Inventory (Q: Mar. 2022 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Dec. 2021 ) | + | Total Inventories (Q: Mar. 2022 )) | / | count ) | / | Cost of Goods Sold (Q: Mar. 2022 ) | * | Days in Period |
= | ( (431 | + | 465) | / | 2 ) | / | 408 | * | 365 / 4 |
= | 448 | / | 408 | * | 365 / 4 | ||||
= | 100.20 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Illumina's Inventory Turnover for the three months ended in Mar. 2022 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 408 | / | 448 | |
= | 0.91 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Illumina's Inventory to Revenue for the three months ended in Mar. 2022 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 448 | / | 1223 | |
= | 0.37 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Illumina's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Frank John Edward | officer: Chief Public Affairs Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Rollins Carissa | officer: SVP, Chief Information Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Pegels Kevin Carl | officer: Chief of Global Operations | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Torres Jose | officer: VP, Chief Accounting Officer | 1300 W. 120TH AVENUE WESTMINSTER CO 80234 |
Reeves Kathryne Gambrell | officer: SVP, Chief Marketing Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Aravanis Alexander | officer: SVP, Chief Technology Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Gottlieb Scott | director | MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142 |
Febbo Phillip G. | officer: SVP Chief Medical Officer | C/O GENOMIC HEALTH, INC. 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 |
Tousi Susan H | officer: SVP Product Development | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Goswami Joydeep | officer: SVP Corp Business Development | SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023 |
Siegel Susan E | director | 3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025 |
Ragusa Robert P | officer: SVP, Global Quality & Ops | |
Hoyt Aimee L | officer: SVP, Chief People Officer | 5200 ILLUMINA WAY SAN DIEGO CA 92122 |
Guthart Gary S | director | C/O INTUITIVE SURGICAL INC 1266 KIFER RD SUNNYVALE CA 94086 |
Mcginnis Karen K | officer: VP, Chief Accounting Officer | INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284 |
From GuruFocus
By PRNewswire 02-03-2022
By PRNewswire 12-23-2021
Other Sources
By Zacks 2022-01-24
By Zacks 2022-02-10
By Fool 2022-01-22
By tipranks.com 2022-03-30
By Zacks 2022-03-18
By Zacks 2022-01-07
By Zacks 2021-12-27
By Zacks 2022-02-11
By Fool 2022-01-11
By Fool 2022-01-11
By Zacks 2022-01-05
By tipranks.com 2022-03-02
By Zacks 2022-01-14
By Zacks 2022-02-09
By Zacks 2022-03-01